Hepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antivirals
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antivirals
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 21, Issue 38, Pages 10749
Publisher
Baishideng Publishing Group Inc.
Online
2015-10-14
DOI
10.3748/wjg.v21.i38.10749
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Telaprevir enhances ribavirin-induced anaemia through renal function impairment
- (2015) Laurent Cotte et al. ANTIVIRAL THERAPY
- Importance of very early HCV RNA kinetics for prediction of treatment outcome of highly effective all oral direct acting antiviral combination therapy
- (2015) Christoph Sarrazin et al. JOURNAL OF VIROLOGICAL METHODS
- TM6SF2 E167K variant is associated with severe steatosis in chronic hepatitis C, regardless of PNPLA3 polymorphism
- (2015) Nicola Coppola et al. LIVER INTERNATIONAL
- Review article: the efficacy and safety of sofosbuvir, a novel, oral nucleotide NS5B polymerase inhibitor, in the treatment of chronic hepatitis C virus infection
- (2014) R. S. Koff ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection
- (2014) Evangelista Sagnelli et al. EXPERT OPINION ON PHARMACOTHERAPY
- ABT-450, Ritonavir, Ombitasvir, and Dasabuvir Achieves 97% and 100% Sustained Virologic Response With or Without Ribavirin in Treatment-Experienced Patients With HCV Genotype 1b Infection
- (2014) Pietro Andreone et al. GASTROENTEROLOGY
- Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment
- (2014) E. Sagnelli et al. INFECTION
- Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
- (2014) Nezam Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3
- (2014) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Peg-Interferon Plus Ribavirin with or without Boceprevir or Telaprevir for HCV Genotype 1: A Meta-Analysis on the Role of Response Predictors
- (2014) Nicola Coppola et al. PLoS One
- Strategy for improving survival and reducing recurrence of HCV-related hepatocellular carcinoma
- (2014) Toru Ishikawa WORLD JOURNAL OF GASTROENTEROLOGY
- Telaprevir combination therapy in HCV/HIV co-infected patients (INSIGHT study): sustained virologic response at 12 weeks final analysis
- (2014) Marisa Montes et al. Journal of the International AIDS Society
- Trends in hepatitis C virus infections among MSM attending a sexually transmitted infection clinic; 1995–2010
- (2013) Anouk T. Urbanus et al. AIDS
- Accuracy of Rapid and Point-of-Care Screening Tests for Hepatitis C
- (2013) Sushmita Shivkumar et al. ANNALS OF INTERNAL MEDICINE
- Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus Infection
- (2013) Roger Chou et al. ANNALS OF INTERNAL MEDICINE
- Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection
- (2013) N. Coppola et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Efficacy of an Interferon- and Ribavirin-Free Regimen of Daclatasvir, Asunaprevir, and BMS-791325 in Treatment-Naive Patients With HCV Genotype 1 Infection
- (2013) Gregory T. Everson et al. GASTROENTEROLOGY
- Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naïve genotype 1 hepatitis C: The randomized PILLAR study
- (2013) Michael W. Fried et al. HEPATOLOGY
- Hepatocellular carcinoma in patients with chronic hepatitis C virus infection in the Asia–Pacific region
- (2013) Mi Na Kim et al. JOURNAL OF GASTROENTEROLOGY
- EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
- (2013) JOURNAL OF HEPATOLOGY
- Risk factors for hepatocellular carcinoma in hepatitis C patients with normal alanine aminotransferase treated with pegylated interferon and ribavirin
- (2013) N. Harada et al. JOURNAL OF VIRAL HEPATITIS
- HIV, HCV, and drug use in men who have sex with men
- (2013) Sean R Hosein et al. LANCET
- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
- (2013) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
- (2013) Eric Lawitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life
- (2013) J. Guedj et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Review article: the diagnosis of non-alcoholic fatty liver disease - availability and accuracy of non-invasive methods
- (2012) D. Festi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Update on the Management and Treatment of Hepatitis C Virus Infection: Recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office
- (2012) Helen S Yee et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Clinical applications of antibody avidity and immunoglobulin M testing in acute HCV infection
- (2012) Evangelista Sagnelli et al. ANTIVIRAL THERAPY
- Efficacy of pegylated interferon α-2a and α-2b in patients with genotype 1 chronic hepatitis C: a meta-analysis
- (2012) Nicola Coppola et al. BMC INFECTIOUS DISEASES
- Sofosbuvir (GS-7977) plus peginterferon/ribavirin in treatment-naïve patients with HCV genotype 1: A randomized, 28-day, dose-ranging trial
- (2012) Maribel Rodriguez-Torres et al. JOURNAL OF HEPATOLOGY
- Efficacy and safety of boceprevir plus peginterferon–ribavirin in patients with HCV G1 infection and advanced fibrosis/cirrhosis
- (2012) Savino Bruno et al. JOURNAL OF HEPATOLOGY
- Prospective Validation of FibroTest in Comparison with Liver Stiffness for Predicting Liver Fibrosis in Asian Subjects with Chronic Hepatitis B
- (2012) Beom Kyung Kim et al. PLoS One
- Performance of Transient Elastography for the Staging of Liver Fibrosis in Patients with Chronic Hepatitis B: A Meta-Analysis
- (2012) Young Eun Chon et al. PLoS One
- Hepatocellular carcinoma in chronic hepatitis C: from bench to bedside
- (2012) Alessio Aghemo et al. Seminars in Immunopathology
- Relationship between polymorphisms of the inosine triphosphatase gene and anaemia or outcome after treatment with pegylated interferon and ribavirin
- (2011) Masayuki Kurosaki et al. ANTIVIRAL THERAPY
- An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases
- (2011) Marc G. Ghany et al. HEPATOLOGY
- Genetic risk of hepatocellular carcinoma in patients with hepatitis C virus: A case control study
- (2011) Takeshi Tomoda et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
- (2011) JOURNAL OF HEPATOLOGY
- Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan
- (2011) Hiromitsu Kumada et al. JOURNAL OF HEPATOLOGY
- Variants in the ITPA Gene Protect Against Ribavirin-Induced Hemolytic Anemia in HIV/HCV-Coinfected Patients With All HCV Genotypes
- (2011) Susanna Naggie et al. JOURNAL OF INFECTIOUS DISEASES
- 2011 European Association of the Study of the Liver hepatitis C virus clinical practice guidelines
- (2011) Vincenza Calvaruso et al. LIVER INTERNATIONAL
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
- (2011) Bruce R. Bacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Retreatment of HCV Infection
- (2011) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection
- (2010) Thijs JW van de Laar et al. AIDS
- ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measure
- (2010) T. Poynard et al. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
- Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus
- (2010) Alexander J. Thompson et al. GASTROENTEROLOGY
- Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease
- (2010) S. McPherson et al. GUT
- Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR
- (2010) Alexander J. Thompson et al. HEPATOLOGY
- Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: An updated meta-analysis
- (2010) Zhong-Hua Lin et al. HEPATOLOGY
- Use of an Anti-Hepatitis C Virus (HCV) IgG Avidity Assay To Identify Recent HCV Infection
- (2010) C. Gaudy-Graffin et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Distinguishing Acute from Chronic Hepatitis C Virus (HCV) Infection Based on Antibody Reactivities to Specific HCV Structural and Nonstructural Proteins
- (2010) A. C. Araujo et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Elastography for the diagnosis of severity of fibrosis in chronic liver disease: A meta-analysis of diagnostic accuracy
- (2010) E.A. Tsochatzis et al. JOURNAL OF HEPATOLOGY
- Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
- (2010) Min Gao et al. NATURE
- ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C
- (2010) Jacques Fellay et al. NATURE
- Correlates and Prognostic Value of the First‐Phase Hepatitis C Virus RNA Kinetics during Treatment
- (2009) Emanuele Durante‐Mangoni et al. CLINICAL INFECTIOUS DISEASES
- Practice guidelines for the treatment of hepatitis C: Recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting
- (2009) DIGESTIVE AND LIVER DISEASE
- Rapid HCV-RNA Decline With Once Daily TMC435: A Phase I Study in Healthy Volunteers and Hepatitis C Patients
- (2009) Henk W. Reesink et al. GASTROENTEROLOGY
- Improvement in the aetiological diagnosis of acute hepatitis C: A diagnostic protocol based on the anti-HCV-IgM titre and IgG Avidity Index
- (2009) Nicola Coppola et al. JOURNAL OF CLINICAL VIROLOGY
- Prevention of hepatocellular carcinoma in the Asia-Pacific region: Consensus statements
- (2009) JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
- (2009) Vijayaprakash Suppiah et al. NATURE GENETICS
- Diagnosis, management, and treatment of hepatitis C: An update
- (2008) Marc G. Ghany et al. HEPATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started